Caricamento...

Toward a Single-Dose Cure for Buruli Ulcer

A single dose of Q203 (Telacebec), a phase 2 clinical candidate for tuberculosis, eradicates Mycobacterium ulcerans in a mouse model of Buruli ulcer infection without relapse up to 19 weeks posttreatment. Clinical use of Q203 may dramatically simplify the clinical management of Buruli ulcer, a negle...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Thomas, Sangeeta S., Kalia, Nitin Pal, Ruf, Marie-Thérèse, Pluschke, Gerd, Pethe, Kevin
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7449209/
https://ncbi.nlm.nih.gov/pubmed/32631818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00727-20
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !